ClinicalTrials.Veeva

Menu

Repairing the Defect of Intervertebral Disc With Autologous BMSC and Gelatin Sponge After Microendoscopic Discectomy for Lumbar Disc Herniation

Z

Zhanghao

Status

Completed

Conditions

Lumbar Disc Herniation

Treatments

Device: Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge
Procedure: The defect is sutured

Study type

Interventional

Funder types

Other

Identifiers

NCT03002207
2016(001)

Details and patient eligibility

About

In this prospective study the investigators seek to evaluate clinical outcomes after repairing the defect of intervertebral disc with autologous BMSC/gelatin sponge during microendoscopic discectomy for participants of lumbar disc herniation.

Full description

The participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not. In the first group,the defect of intervertebral disc is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge and sutured. In the second group, the defect of intervertebral disc is repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge but not sutured after discectomy. In the third group, the defect of intervertebral disc is sutured but not repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy. In the four group, the defect of intervertebral disc is neither sutured nor repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy.

Enrollment

25 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Participants with signs and symptoms of lumbar disc herniation requiring surgical treatment after conservative management;
  2. Radiological data on CT/MRI obtained within a period prior to enrollment;
  3. Participants give written informed consent before enrollment.

Exclusion criteria

  1. If participants had an incomplete medical record;
  2. Participants had spine tumor, spine infection, previous underwent lumbar surgery, or revision surgery.
  3. Participants are taking uninterruptible anticoagulation therapy.
  4. Dementia and/or inability to give informed consent.
  5. MRI contraindication (e.g. cerebral aneurysm clips, cochlear implants, pacemaker, implanted biostimulators);
  6. Pregnancy;
  7. Participation in other clinical trial within the last 30 days.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

25 participants in 4 patient groups

The defect is repaired and sutured
Experimental group
Description:
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not. In the first group,the defect of intervertebral disc is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge and sutured.
Treatment:
Procedure: The defect is sutured
Device: Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge
The defect is repaired but not sutured
Experimental group
Description:
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not. In the second group, the defect of intervertebral disc is repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge but not sutured after discectomy.
Treatment:
Device: Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge
The defect is sutured but not repaired
Experimental group
Description:
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not. In the third group, the defect of intervertebral disc is sutured but not repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy.
Treatment:
Procedure: The defect is sutured
The defect is neither sutured nor repaired
No Intervention group
Description:
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not. In the four group, the defect of intervertebral disc is neither sutured nor repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy.

Trial contacts and locations

1

Loading...

Central trial contact

Baoshan Xu; Yue Liu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems